Abstract
The development of a solitary chest wall mass due to underlying malignant lymphoma is an uncommon clinical presentation. Diffuse large B-cell lymphoma, a type of non-Hodgkin's lymphoma, can affect multiple organs including the lungs and pleural space. In some instances, there may be preexisting inflammation such as a chronic pyothorax before lymphoma arises in these locations. Diffuse large B-cell lymphoma may frequently disseminate to extranodal sites, but involvement of the chest wall has been reported in nearly 100 cases. This report details an unusual presentation of diffuse large B-cell lymphoma from an enlarging chest wall mass and an underlying lymphomatous pleural effusion.
Keywords: Chest wall mass, lymphoma, pleural effusion, pyothorax.
Current Respiratory Medicine Reviews
Title:Diffuse Large B-Cell Lymphoma with Involvement of the Chest Wall
Volume: 9 Issue: 2
Author(s): William H. Porr, Jonathan L. Henderson and Michael J. Morris
Affiliation:
Keywords: Chest wall mass, lymphoma, pleural effusion, pyothorax.
Abstract: The development of a solitary chest wall mass due to underlying malignant lymphoma is an uncommon clinical presentation. Diffuse large B-cell lymphoma, a type of non-Hodgkin's lymphoma, can affect multiple organs including the lungs and pleural space. In some instances, there may be preexisting inflammation such as a chronic pyothorax before lymphoma arises in these locations. Diffuse large B-cell lymphoma may frequently disseminate to extranodal sites, but involvement of the chest wall has been reported in nearly 100 cases. This report details an unusual presentation of diffuse large B-cell lymphoma from an enlarging chest wall mass and an underlying lymphomatous pleural effusion.
Export Options
About this article
Cite this article as:
Porr H. William, Henderson L. Jonathan and Morris J. Michael, Diffuse Large B-Cell Lymphoma with Involvement of the Chest Wall, Current Respiratory Medicine Reviews 2013; 9 (2) . https://dx.doi.org/10.2174/1573398X11309020002
DOI https://dx.doi.org/10.2174/1573398X11309020002 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cell and Gene Therapies in Cardiovascular Disease with Special Focus on the No Option Patient
Current Gene Therapy Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring
Current Pharmacogenomics Carfilzomib: A Tale of a Heartbreaking Moment: Case Report and Concise Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies
Current Gene Therapy Epigenetic Alterations of the Wnt/β -Catenin Pathway in Human Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Remodeling of the Insulin Receptor Pathway by Thiazolidinediones in Type 2 Diabetes Mellitus: A Brief Review
Protein & Peptide Letters A Novel Lily-of-the-Valley Fragrance Contrast Agent for Magnetic Resonance and Fluorescence Imaging of Prostate Cancer Cells
Current Pharmaceutical Biotechnology Vitamin D and Vitamin D Analogs in Cancer Treatment
Current Drug Targets Small-molecule Inhibitors of Epigenetic Mutations as Compelling Drugtargets for Myelodysplastic Syndromes
Current Cancer Drug Targets Reduced Nicotinamide Adenine Dinucleotide (NADH) Fluorescence for the Detection of Cell Death
Anti-Cancer Agents in Medicinal Chemistry The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer
Current Signal Transduction Therapy Pharmacological Modulation of Caspase Activation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Targeting of NF-kappaB Signaling Pathway, other Signaling Pathways and Epigenetics in Therapy of Multiple Myeloma
Cardiovascular & Hematological Disorders-Drug Targets Methods of Screening-Purification and Antimicrobial Potentialities of Bacteriocin in Health Care
Current Drug Metabolism Cancer Stem Cells: A New Paradigm for Understanding Tumor Growth and Progression and Drug Resistance
Current Medicinal Chemistry Subject index to volume 3
Current Molecular Medicine Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Current Medicinal Chemistry In Vitro Models of Human T Cell Development: Dishing Out Progenitor T Cells
Current Immunology Reviews (Discontinued) Anti-cancer and Other Bioactivities of Korean Angelica gigas Nakai (AGN) and Its Major Pyranocoumarin Compounds
Anti-Cancer Agents in Medicinal Chemistry Molecular Targets for the Treatment of Testicular Germ Cell Tumors
Mini-Reviews in Medicinal Chemistry